Načítá se...
COVID-19 convalescent plasma composition and immunological effects in severe patients
Convalescent plasma (CP) has emerged as a treatment for COVID-19. However, the composition and mechanism of action are not fully known. Therefore, we undertook a two-phase controlled study in which, first the immunological and metabolomic status of recovered and severe patients were evaluated. Secon...
Uloženo v:
| Vydáno v: | J Autoimmun |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Authors. Published by Elsevier Ltd.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826092/ https://ncbi.nlm.nih.gov/pubmed/33524876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2021.102598 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|